Message-ID: <17055965.1075842126892.JavaMail.evans@thyme>
Date: Fri, 16 Jun 2000 04:17:00 -0700 (PDT)
From: carol.clair@enron.com
To: jarrod.cyprow@enron.com
Subject: Re: Annex B for New England Serum Company, Inc. Deal No. NM9569.1
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-From: Carol St Clair
X-To: Jarrod Cyprow
X-cc: 
X-bcc: 
X-Folder: \Carol_StClair_Dec2000_1\Notes Folders\Sent
X-Origin: STCLAIR-C
X-FileName: cstclai.nsf

Jarrod:
Here is the revised confirm.  As we discussed, the only other change that 
they need to have made is to change Texas to New York in Section 6 of annex A.
Carol





	Jarrod Cyprow
	06/16/2000 10:29 AM
		 
		 To: Carol St Clair/HOU/ECT@ECT
		 cc: 
		 Subject: Annex B for New England Serum Company, Inc. Deal No. NM9569.1

Per Paul Radous in Credit, the amount of the LC was changed to $150,000.


---------------------- Forwarded by Jarrod Cyprow/HOU/ECT on 06/16/2000 10:29 
AM ---------------------------


Susan Flynn
06/14/2000 02:20 PM
To: Jarrod Cyprow/HOU/ECT@ECT, Scott M Shields/HOU/ECT@ECT
cc: Paul Radous/Corp/Enron@ENRON, Carol St Clair/HOU/ECT@ECT 
Subject: Annex B for New England Serum Company, Inc.   Deal No.  NM9569.1







Susan D. Flynn
Enron North America Corp.
1400 Smith Street, EB3806
Houston, Texas  77002
Phone:  713-853-0975
Fax:  713-646-3490


